These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3079388)

  • 1. Anthracyclines.
    Myers C
    Cancer Chemother Biol Response Modif; 1988; 10():33-9. PubMed ID: 3079388
    [No Abstract]   [Full Text] [Related]  

  • 2. Anthracyclines.
    Myers C
    Cancer Chemother Biol Response Modif; 1987; 9():36-49. PubMed ID: 3079408
    [No Abstract]   [Full Text] [Related]  

  • 3. Anthracyclines.
    Myers CE
    Cancer Chemother Biol Response Modif; 1992; 13():45-52. PubMed ID: 1389917
    [No Abstract]   [Full Text] [Related]  

  • 4. Modes of resistance to anthracyclines and other natural products.
    Kessel D; Romine M; Decker D
    Prog Clin Biol Res; 1986; 223():81-93. PubMed ID: 3543948
    [No Abstract]   [Full Text] [Related]  

  • 5. DNA topoisomerase inhibitors.
    D'Incalci M; Capranico G; Giaccone G; Zunino F; Garattini S
    Cancer Chemother Biol Response Modif; 1993; 14():61-85. PubMed ID: 8312123
    [No Abstract]   [Full Text] [Related]  

  • 6. Preclinical selection of new anthracyclines.
    Casazza AM
    Cancer Treat Rep; 1986 Jan; 70(1):43-9. PubMed ID: 3510737
    [No Abstract]   [Full Text] [Related]  

  • 7. Infusional anthracyclines: is slower better? If so, why?
    Workman P
    Ann Oncol; 1992 Sep; 3(8):591-4. PubMed ID: 1450039
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
    Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
    Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation and resistance to mitomycin C.
    Seow HA; Penketh PG; Baumann RP; Sartorelli AC
    Methods Enzymol; 2004; 382():221-33. PubMed ID: 15047104
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythrocytes as carriers of anthracycline antibiotics].
    Tikhonova AG; Aleksandrovich IuG; Vuĭmo TA; Sinauridze EI; Ataullakhanov FI
    Ter Arkh; 2008; 80(7):91-4. PubMed ID: 18763609
    [No Abstract]   [Full Text] [Related]  

  • 11. Structurally modified anthracyclines retain activity in a cell line with simultaneous typical and atypical multidrug resistance.
    Bielack SS; Kallenbach K; Looft G; Erttmann R; Winkler K
    Anticancer Res; 1995; 15(4):1279-84. PubMed ID: 7654009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular pharmacokinetics of anthracyclines in human leukemia cells: correlation of DNA-binding with apoptotic cell death.
    Gieseler F; Nüssler V; Brieden T; Kunze J; Valsamas S
    Int J Clin Pharmacol Ther; 1998 Jan; 36(1):25-8. PubMed ID: 9476145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety.
    Sztaricskai F; Sum A; Roth E; Pelyvás IF; Sándor S; Batta G; Herczegh P; Reményi J; Miklán Z; Hudecz F
    J Antibiot (Tokyo); 2005 Nov; 58(11):704-14. PubMed ID: 16466024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idarubicin: a brief overview on pharmacology and clinical use.
    Borchmann P; Hübel K; Schnell R; Engert A
    Int J Clin Pharmacol Ther; 1997 Feb; 35(2):80-3. PubMed ID: 9147715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sugar-recognizing antibiotics, pradimicins].
    Oki T
    Tanpakushitsu Kakusan Koso; 1994 May; 39(6):973-8. PubMed ID: 8184107
    [No Abstract]   [Full Text] [Related]  

  • 16. Poly (ethylene glycol) prodrug for anthracyclines via N-Mannich base linker: design, synthesis and biological evaluation.
    Zhao YJ; Wei W; Su ZG; Ma GH
    Int J Pharm; 2009 Sep; 379(1):90-9. PubMed ID: 19540322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical mechanism for resistance to anthracycline antibiotics.
    Inaba M
    Prog Clin Biol Res; 1986; 223():35-44. PubMed ID: 3468518
    [No Abstract]   [Full Text] [Related]  

  • 18. Anthracyclines.
    Batist G
    Cancer Chemother Biol Response Modif; 2001; 19():47-58. PubMed ID: 11686029
    [No Abstract]   [Full Text] [Related]  

  • 19. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity.
    Faderl S; Estrov Z; Kantarjian HM; Harris D; Van Q; Fokt I; Przewloka T; Godlewski C; Woynarowski JM; Priebe W
    Anticancer Res; 2001; 21(6A):3777-84. PubMed ID: 11911247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.